Alimera Sciences Inc (ALIM)
3.60
+0.03
(+0.84%)
USD |
NASDAQ |
Apr 24, 16:00
3.60
0.00 (0.00%)
After-Hours: 19:17
Alimera Sciences Profit Margin (Quarterly): -14.37% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.37% |
| September 30, 2023 | -5.80% |
| June 30, 2023 | -57.18% |
| March 31, 2023 | -36.68% |
| December 31, 2022 | -26.94% |
| September 30, 2022 | -38.66% |
| June 30, 2022 | -21.33% |
| March 31, 2022 | -50.05% |
| December 31, 2021 | -29.41% |
| September 30, 2021 | -34.42% |
| June 30, 2021 | 34.86% |
| March 31, 2021 | -32.53% |
| December 31, 2020 | -7.09% |
| September 30, 2020 | -4.95% |
| June 30, 2020 | -25.36% |
| March 31, 2020 | -8.24% |
| December 31, 2019 | 2.87% |
| September 30, 2019 | -24.44% |
| June 30, 2019 | -46.41% |
| March 31, 2019 | -21.44% |
| December 31, 2018 | -8.26% |
| September 30, 2018 | -30.98% |
| Date | Value |
|---|---|
| June 30, 2018 | -37.32% |
| March 31, 2018 | -79.79% |
| December 31, 2017 | -79.02% |
| September 30, 2017 | -54.02% |
| June 30, 2017 | -26.59% |
| March 31, 2017 | -101.8% |
| December 31, 2016 | -55.50% |
| September 30, 2016 | -111.4% |
| June 30, 2016 | -71.76% |
| March 31, 2016 | -192.1% |
| December 31, 2015 | -184.0% |
| September 30, 2015 | -22.36% |
| June 30, 2015 | -148.8% |
| March 31, 2015 | -248.7% |
| December 31, 2014 | -531.8% |
| September 30, 2014 | -291.1% |
| June 30, 2014 | 50.96% |
| March 31, 2014 | -996.1% |
| December 31, 2013 | -1.58K% |
| September 30, 2013 | -146.8% |
| June 30, 2013 | -9.14K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-57.18%
Minimum
Jun 2023
34.86%
Maximum
Jun 2021
-22.43%
Average
-25.36%
Median
Jun 2020
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 23.41% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -99.16% |
| Return on Assets | -18.19% |
| Return on Invested Capital | -26.33% |
| Gross Profit Margin (Quarterly) | 86.22% |
| Operating Margin (Quarterly) | 2.75% |
| Return on Net Operating Assets | -21.10% |